Today’s cyclodextrin is a recent innovation from Roquette.
KLEPTOSE® F 7% – EXP beta-cyclodextrin offers consistent particle size, low moisture (4-7%), and enhanced stability for moisture-sensitive APIs. Designed for chewables, ODTs, and effervescent tablets, it ensures excellent tabletability and batch-to-batch consistency at high-speed compression. Better stability, better performance.
Event Overview: Join us for an illuminating webinar that traces the evolution of cyclodextrin-based drug delivery systems—from laboratory research to real-world patient care. Our esteemed speakers will explore key aspects of this journey, highlighting breakthroughs, challenges, and the promise of cyclodextrins in improving therapeutic outcomes.
Agenda:
Preparation of Parenteral and Oral Cyclodextrin-Based Formulations and Their Physical Characterization
Speaker: Dr. Carmen Popescu (Roquette)
Dr. Popescu will unveil the meticulous process of formulating cyclodextrin-based drugs for parenteral and oral administration. From solubility enhancement to stability studies, discover how cyclodextrins bridge the gap between lab experiments and clinical applications.
Cyclodextrins in Liquid, Transdermal, and Other Non-Traditional Forms
Speaker: Dr. Balazs Kondoros (CarboHyde)
Dr. Kondoros will guide us beyond conventional dosage forms. Explore how cyclodextrins revolutionize liquid formulations, transdermal patches, and other innovative delivery methods. Witness the transition from theoretical concepts to practical solutions.
Hunting for Cyclodextrins: Analytical Assay Methods in Biological Fluids
Speaker: Dr. Tamas Sohajda (Carbohyde)
Dr. Sohajda’s presentation focuses on the detective work involved in studying cyclodextrins within biological matrices. Learn about cutting-edge assay techniques, their role in clinical trials, and the critical insights they provide.
Promising Future for HPBCD in Inhalation
Speaker: Dr. Natacha Rocks (Aquilon)
Dr. Rocks will unveil the exciting prospects of hydroxypropyl-β-cyclodextrin (HPBCD) in inhalation therapies. From lung-targeted drug delivery to patient-friendly devices, witness how cyclodextrins are poised to transform respiratory medicine.
